7-147977856-A-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014141.6(CNTNAP2):​c.2256-6A>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0673 in 1,612,480 control chromosomes in the GnomAD database, including 4,888 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 1088 hom., cov: 31)
Exomes 𝑓: 0.064 ( 3800 hom. )

Consequence

CNTNAP2
NM_014141.6 splice_region, intron

Scores

2
Splicing: ADA: 0.0004320
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.433
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 7-147977856-A-T is Benign according to our data. Variant chr7-147977856-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 95561.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-147977856-A-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.197 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CNTNAP2NM_014141.6 linkuse as main transcriptc.2256-6A>T splice_region_variant, intron_variant ENST00000361727.8 NP_054860.1 Q9UHC6-1A0A090N7T7B2RCH4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkuse as main transcriptc.2256-6A>T splice_region_variant, intron_variant 1 NM_014141.6 ENSP00000354778.3 Q9UHC6-1

Frequencies

GnomAD3 genomes
AF:
0.104
AC:
15811
AN:
151980
Hom.:
1091
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.201
Gnomad AMI
AF:
0.0285
Gnomad AMR
AF:
0.0661
Gnomad ASJ
AF:
0.0876
Gnomad EAS
AF:
0.175
Gnomad SAS
AF:
0.0485
Gnomad FIN
AF:
0.0689
Gnomad MID
AF:
0.0886
Gnomad NFE
AF:
0.0599
Gnomad OTH
AF:
0.0967
GnomAD3 exomes
AF:
0.0774
AC:
19470
AN:
251400
Hom.:
1076
AF XY:
0.0734
AC XY:
9972
AN XY:
135870
show subpopulations
Gnomad AFR exome
AF:
0.206
Gnomad AMR exome
AF:
0.0567
Gnomad ASJ exome
AF:
0.0811
Gnomad EAS exome
AF:
0.184
Gnomad SAS exome
AF:
0.0463
Gnomad FIN exome
AF:
0.0641
Gnomad NFE exome
AF:
0.0591
Gnomad OTH exome
AF:
0.0719
GnomAD4 exome
AF:
0.0635
AC:
92739
AN:
1460382
Hom.:
3800
Cov.:
33
AF XY:
0.0629
AC XY:
45677
AN XY:
726598
show subpopulations
Gnomad4 AFR exome
AF:
0.206
Gnomad4 AMR exome
AF:
0.0585
Gnomad4 ASJ exome
AF:
0.0803
Gnomad4 EAS exome
AF:
0.176
Gnomad4 SAS exome
AF:
0.0476
Gnomad4 FIN exome
AF:
0.0624
Gnomad4 NFE exome
AF:
0.0556
Gnomad4 OTH exome
AF:
0.0750
GnomAD4 genome
AF:
0.104
AC:
15823
AN:
152098
Hom.:
1088
Cov.:
31
AF XY:
0.103
AC XY:
7648
AN XY:
74380
show subpopulations
Gnomad4 AFR
AF:
0.201
Gnomad4 AMR
AF:
0.0660
Gnomad4 ASJ
AF:
0.0876
Gnomad4 EAS
AF:
0.175
Gnomad4 SAS
AF:
0.0490
Gnomad4 FIN
AF:
0.0689
Gnomad4 NFE
AF:
0.0599
Gnomad4 OTH
AF:
0.0953
Alfa
AF:
0.0710
Hom.:
167
Bravo
AF:
0.110
Asia WGS
AF:
0.115
AC:
400
AN:
3478
EpiCase
AF:
0.0602
EpiControl
AF:
0.0599

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 27, 2013- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsAug 17, 2017- -
Cortical dysplasia-focal epilepsy syndrome Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Pitt-Hopkins-like syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
11
DANN
Benign
0.78

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00043
dbscSNV1_RF
Benign
0.036
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10240482; hg19: chr7-147674948; COSMIC: COSV62158216; API